Salute e Benessere

One of the largest multi-region healthcare systems in the US expands enterprise…

The pathology module allows pathologists to review and collaborate around cases digitally as well as benefit from AI tools. The digital workflow provides instant and, when needed, remote access to digital images of tissue samples instead of relying on physical glass slides reviewed in microscopes. With their pathologists and radiologists now sharing a unified system, it will pave the way for integrated diagnostics, which makes collaboration across different specialties more effective. The...
PR Newswire
07/07/2025

Biosolutions could create more than 600,000 jobs and unlock hundreds of billions…

Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for EuropeA new report reveals that biosolutions could generate EUR 133 billion in economic gains and create over 600,000 jobs across all of Europe by 2035. But without urgent policy leadership and better regulation, Europe risks becoming the world’s best lab for solutions that scale elsewhere. Copenhagen, Denmark – 7 July 2025: Europe is on the verge of a job and growth boom if biosolutions are...
Nasdaq GlobeNewswire
07/07/2025

Eleva administers first dose of its Factor H biological treatment in…

First-in-human administration of CPV-104 marks a major step in drug development for the company’s lead compound (Factor H) and in bringing a new medication to patientsFreiburg im Breisgau, Germany, July 7, 2025 – Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, announced today the first dosing in its Phase 1 clinical study investigating the company’s Factor H (CPV-104) program in C3-Glomerulopathy (C3G)...
Nasdaq GlobeNewswire
07/07/2025

ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison…

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)Denison is Professor of Clinical Neurosciences at the University of Oxford and was previously Vice President of Research and Core Technologies at Medtronic. He is a co-founder and Chief Engineer of neurotechnology company Amber Therapeutics.ONWARD Co-Founder Professor Gregoire Courtine will continue to serve as Science Advisor. He will depart the Board of...
Nasdaq GlobeNewswire
07/07/2025

JUICE PLUS LAUNCHES SUPERFOOD POWDER: A POWERHOUSE OF PLANT-BASED NUTRITION IN…

Superfood Powder is a delicious blend designed to support the immune system[1], oxidative stress protection[2], skin health[3], dental health[4] and more. A vibrant fusion of greens, reds and purples – enhanced with plant-based vitamins and phytonutrients. Each pre-portioned stick pack boasts an unmatched taste* while ensuring maximum convenience, allowing busy individuals to get a delicious daily dose of plant-based nutrition anytime. Simply mix with 300ml of water , stir well and drink! ...
PR Newswire
07/07/2025

Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial markets authority)Listing market: Euronext GrowthISIN code: FR0010425595DateTotal number of shares in the capitalTotal number of voting rights 06/30/2025100,325,22989,428,630 For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,[email protected] Patricia Sosa Navarro, Chief of Staff to the...
Nasdaq GlobeNewswire
04/07/2025

OXURION : Information on the Total Number of Voting Rights (Denominator)…

Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1] that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential market…
Actusnews Wire
04/07/2025

Wearable EEG Devices Market Size to Grow by USD 695.51 million by 2031…

To explore the valuable insights in the Wearable EEG Devices Market report, you can easily download a sample PDF of the report. -https://www.theinsightpartners.com/sample/TIPRE00007291 To explore the valuable insights in the Wearable EEG Devices Market report, you can easily download a sample PDF of the report. -https://www.theinsightpartners.com/sample/TIPRE00007291 This is in contrast to traditional EEG setups, which are usually restricted to hospital or clinical contexts and need...
PR Newswire
04/07/2025

$0.71 Billion by 2032: Why Digital Stethoscopes Are Transforming Modern…

The global digital stethoscopes market, valued at US$0.49 billion in 2025, is projected to grow at a robust CAGR of 5.5%, reaching US$0.71 billion by 2032. This growth is fueled by the increasing burden of chronic cardiovascular and respiratory diseases, the rise of telemedicine, and the demand for remote patient monitoring (RPM). As healthcare evolves toward decentralization and digitization, digital stethoscopes are becoming essential tools—not just for diagnosis, but for real-time care…
PR Newswire
04/07/2025

DoH, USCF and IGI Explore Establishing the World's first-of-their kind Centres…

Genome surgery is an experimental medical technique aimed at modifying or replacing faulty genes within cells to treat or prevent diseases. This is achieved through personalised genetic therapies or by using advanced technologies such as CRISPR, which can be tailored specifically to each patient based on their unique genetic mutations. Genome surgery is an experimental medical technique aimed at modifying or replacing faulty genes within cells to treat or prevent diseases. This is achieved...
PR Newswire
04/07/2025

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving…

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman have joined Immuthera’s Scientific Advisory Board.Immuthera will continue expanding its Scientific Advisory Board over the coming months to build a truly world-class team.In collaboration with PolTREG and leading U.S. academic centers, Immuthera will be developing a...
Nasdaq GlobeNewswire
04/07/2025

Virbac : Declaration of the number of shares and voting rights 06/2025

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577DateTotal number of shares representing the share capitalTotal number of voting rightsJune, 30 20258 390 660Gross total of voting rights :...
Nasdaq GlobeNewswire
04/07/2025

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase…

PRESS RELEASEMASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN PATIENT SELECTION TARGETING POPULATION MOST LIKELY TO BENEFITParis, July 4, 2025, 8am CETAB Science SA(Euronext - FR0010557264 - AB) today announced that a confirmatory phase 3 trial of masitinib in metastatic castrate resistant prostate cancer (study AB22007) has been authorized by FDA and EMA (harmonized protocol...
Nasdaq GlobeNewswire
04/07/2025

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of Araris Biotech, from a group of outstanding life science entrepreneursThe founding team is developing a breakthrough technology to establish a new generation of targeted cancer therapiesCommittee representatives presented the award and the EUR 100,000 cash prize on Thursday, July 3, 2025 Munich, Germany, July 04, 2025 – The Strüngmann Award selection committee...
Nasdaq GlobeNewswire
04/07/2025

Orion publishes Half-Year Financial Report for January–June 2025 and holds a…

ORION CORPORATIONPRESS RELEASE4 JULY 2025 at 09.00 EEST Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025 Orion will publish Half-Year Financial Report for January–June 2025 on Friday, 18 July 2025 at approximately 12.00 noon EEST. The report and related presentation material will be available on the company’s website atwww.orionpharma.com/investorsafter publishing. Webcast and conference call A webcast...
Nasdaq GlobeNewswire
04/07/2025

Notification for the purposes of article 13 of the Luxembourg law of 11 January…

Luxembourg (July 3, 2025)– Alvotech S.A. announces that on June 25, 2025, the proportion of own shares held by Alvotech S.A. reached 6.73%, crossing above the 5% threshold of the total number of voting rights. The above percentage has been calculated on the basis of 22,484,087 own shares out of 334,038,147 shares in issue to which voting rights are attached.
Nasdaq GlobeNewswire
04/07/2025

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the…

Key Takeaways from the GPRC5D-directed Therapies Market Report Key Takeaways from the GPRC5D-directed Therapies Market Report Discover which indication is expected to grab the major GPRC5D-directed therapies market share @ GPRC5D-directed Therapies Market Report GPRC5D-directed Therapies Market Dynamics The GPRC5D-directed therapies market is emerging as a significant focus within the landscape of multiple myeloma treatment. GPRC5D is an orphan receptor predominantly expressed...
PR Newswire
03/07/2025

Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen…

Corporate Updates Corporate Updates Resignation of Director and Executive Chairman Ron Mayronhas resigned as Executive Chairman and a Director of the Company effectiveJuly 1, 2025. Mr. Mayron will remain with the Company for three additional months as a Special Consultant for the Company. In his place, Iris Bincovich, a current Director of the Company, will be temporarily holding the position of Chair of the Company. Iris Bincovich, Chief Executive Officer and Chair of the...
PR Newswire
03/07/2025

Spineway : GMED approval for new production line dedicated to ESP prostheses -…

Press release Ecully, July 3, 2025 – 6:30 p.m. SPINEWAYGMED approval for new production line dedicated to ESP prosthesesFirst production of LP-ESP intervertebral disc prostheses Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its subsidiary Spine Innovations has receivedGMED(French notified body) approval for its new production line dedicated to its LP-ESP and CP-ESP intervertebral disc prostheses...
Nasdaq GlobeNewswire
03/07/2025

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II…

Leuven, BELGIUM – July 3, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on July 3, 2025, from Atlas Special…
Actusnews Wire
03/07/2025

VALNEVA Declaration of shares and voting rights: June 30, 2025

VALNEVADeclaration of shares and voting rightsJune 30, 2025__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment B Declaration date: July 3, 2025 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the change ...
Nasdaq GlobeNewswire
03/07/2025

$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global…

The global single-use surgical instruments market, valued at US$5.60 billion in 2024, stood at US$5.92 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.80 billion by the end of the period. This growth is being driven by the rise of minimally invasive, short-stay, and outpatient surgeries—procedures that demand efficiency, sterility, and speed. Disposable tools are no longer just convenient—they are…
PR Newswire
03/07/2025

Machine Tools Market worth $105.11 billion by 2032 | MarketsandMarkets

Browse in-depth TOC on "Machine Tools Market" Browse in-depth TOC on "Machine Tools Market" 221 - Tables 83 - Figures 260 - Pages Milling machines are estimated to hold a prominent share in 2025 Milling machines hold a prominent share in the machine tools market due to their versatility in performing high-precision operations such as face milling, shoulder milling, and contouring across a wide range of materials and industries. Their dominance is further strengthened by...
PR Newswire
03/07/2025

PharmaVentures Appoints Samara Ferguson as Vice President to Lead Pricing and…

Samara's consultancy experience also brings many years of insight across numerous therapy areas, where she rigorously pressure-tested market access and price potential, developed market access strategies, evidence generation plans, and bespoke real-world studies. Samara's consultancy experience also brings many years of insight across numerous therapy areas, where she rigorously pressure-tested market access and price potential, developed market access strategies, evidence generation plans…
PR Newswire
03/07/2025
Altri  Comunicati